U.S. Markets closed

Rigel Pharmaceuticals, Inc. (RIGL)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
2.81-0.03 (-1.06%)
At close: 4:00PM EDT

2.81 0.00 (0.00%)
After hours: 5:04PM EDT

People also watch
Full screen
Previous Close2.84
Bid2.00 x 200
Ask3.03 x 500
Day's Range2.78 - 2.85
52 Week Range1.94 - 4.38
Avg. Volume1,002,870
Market Cap344.04M
PE Ratio (TTM)-4.19
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube6 days ago

    Rigel Pharmaceuticals, Inc. – Value Analysis (NASDAQ:RIGL) : June 22, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Rigel Pharmaceuticals, Inc. a score of 18. Our analysis is based on comparing Rigel Pharmaceuticals, Inc. with the following peers – Chemocentryx, Inc., Infinity Pharmaceuticals, Inc., Innoviva, Inc., Windtree Therapeutics, Inc., Aradigm Corporation, Mylan N.V., Astrazeneca PLC Sponsored ADR, Acura Pharmaceuticals, Inc., Amgen Inc. and Sangamo Therapeutics, ... Read more (Read more...)

  • Rigel Pharmaceuticals' NDA for Tavalisse Accepted by FDA
    Zacks8 days ago

    Rigel Pharmaceuticals' NDA for Tavalisse Accepted by FDA

    Rigel Pharmaceuticals, Inc. (RIGL) announced that the FDA has accepted its new drug application (NDA) seeking approval for its oral spleen tyrosine kinase inhibitor, fostamatinib for the treatment of patients with chronic and persistent immune thrombocytopenia

  • Zacks8 days ago

    Company News for June 20, 2017

    Companies in the News are: RICE,EQT,RIGL,NVDQ,SYK,VRX